Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 118, 2012 - Issue 2
281
Views
28
CrossRef citations to date
0
Altmetric
Review Article

Platelet-mediated vascular dysfunction during acute lung injury

, &
Pages 72-82 | Received 09 Jan 2012, Accepted 06 Feb 2012, Published online: 23 Mar 2012

References

  • Al-Mehdi AB, Zhao G, Dodia C, Tozawa K, Costa K, Muzykantov V, Ross C, Blecha F, Dinauer M, Fisher AB. (1998). Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ Res 83:730–37.
  • Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. (2000). Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 95:1694–702.
  • Alberts MJ, Atkinson R. (2004). Risk reduction strategies in ischaemic stroke: the role of antiplatelet therapy. Clin Drug Investig 24(5):245–54.
  • Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, Ward PA. (2002). Ischemia/reperfusion injury. J Surg Res 105:248–58.
  • André P, Srinivasa Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD. (2002). CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 8:247–52.
  • Asaduzzaman M, Lavasani S, Rahman M, Zhang S, Braun OO, Jeppsson B, Thorlacius H. (2009). Platelets support pulmonary recruitment of neutrophils in abdominal sepsis. Crit Care Med 37(4):1389–96.
  • Azizova OA, Piryazev AP, Aseychev AV, Shvachko AG. (2009). Oxidative modification of fibrinogen inhibits its transformation into fibrin under the effect of thrombin. Bull Exp Biol Med 147(2):201–3.
  • Azuma H, Ishikawa M, Sekizaki S. (1986). Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 88:411–5.
  • Baeuerle PA, Baltimore D. (1996). NF-kappa B: ten years after. Cell 87:13–20.
  • Baglia FA, Walsh PN. (2000). Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa. J Biol Chem 275:20514–19.
  • Beckman JS, Koppenol WH. (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424–37.
  • Brass LF. (2003). Thrombin and platelet activation. Chest 124(3):18S–25S.
  • Brindicci C, Kharitonov SA, Ito M, Elliott MW, Hogg JC, Barnes PJ, Ito K. (2010). Nitric oxide synthase isoenzyme expression and activity in peripheral lung tissue of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181(1):21–30.
  • Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. (2006). Neutrophils in development of multiple organ failure in sepsis. Lancet 368:157–69.
  • Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM. (1996). Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 75(1):77–85.
  • Canobbio I, Bertoni A, Lova P, Paganini S, Hirsch E, Sinigaglia F, Balduini C, Torti M. (2001). Platelet activation by von Willebrand factor requires coordinated signalling through thromboxane A2 and Fc gamma IIA receptor. J Biol Chem 276(28):26022–9.
  • Carbajal JM, Gratrix ML, Yu CH, Schaeffer RC Jr. (2000). ROCK mediates thrombin’s endothelial barrier dysfunction. Am J Physiol Cell Physiol 279(1):C195–204.
  • Carden DL, Granger DN. (2000). Pathophysiology of ischaemia-reperfusion injury. J Pathol 190:255–66.
  • Chakrabarti S, Clutton P, Varghese S, Cox D, Mascelli MA, Freedman JE. (2004). Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release. Thromb Res 113(3–4):225–33.
  • Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R. (2000). Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101:1833–9.
  • Chintala MS, Bernardino V, Chiu PJ. (1994). Cyclic GMP but not cyclic AMP prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats. J Pharmacol Exp Ther 271(3):1203–8.
  • Coller BS. (2008). The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood 112(8):3011–25.
  • Cooper D, Stokes KY, Tailor A, Granger DN. (2002). Oxidative stress promotes blood cell-endothelial cell interactions in the microcirculation. Cardiovasc Toxicol 2(3):165–80.
  • Coughlin SR. (2000). Thrombin signalling and protease activated receptors. Nature 407(6801):258–64.
  • Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB, Kunapuli SP. (1998). Molecular basis for ADP-induced platelet activation. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 273(4):2024–9.
  • Davi G, Patrono C. (2007). Platelet activation and atherothrombosis. N Engl J Med 357(24):2482–94.
  • Davis KL, Martin E, Turko IV, Murad F. (2001). Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41:203–36.
  • De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK. (1995). Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96(1):60–68.
  • den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL. (2010). Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol 299(5):H1283–99.
  • Dudek SM, Garcia JG. (2001). Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91(4):1487–500.
  • Erlich JH, Boyle EM, Labriola J, Kovacich JC, Santucci RA, Fearns C, Morgan EN, Yun W, Luther T, Kojikawa O et al. (2000). Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol 157(6):1849–62.
  • Finigan JH. (2009). The coagulation system and pulmonary endothelial function in acute lung injury. Microvasc Res 77(1):35–8.
  • Gawaz M. (2004). Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 61(3):498–511.
  • Gilles S, Zahler S, Welsch U, Sommerhoff CP, Becker BF. (2003). Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc Res 60(3):608–16.
  • Go YM, Patel RP, Maland MC, Park H, Beckman JS, Darley-Usmar VM, Jo H. (1999). Evidence for peroxynitrite as a signalling molecule in flow-dependent activation of c-Jun NH(2)-terminal kinase. Am J Physiol 277(4):H1647–53.
  • Gole MD, Souza JM, Choi I, Hertkorn C, Malcolm S, Foust RF III, Finkel B, Lanken PN, Ischiropoulos H. (2000). Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 278(5):L961–7.
  • Gratton JP, Fontana J, O’Connor DS, Garciá-Cardeña G, McCabe TJ, Sessa WC. (2000). Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro: Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J Biol Chem 275(29):22268–72.
  • Griendling KK, FitzGerald GA. (2003). Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108(16):1912–6.
  • Guo FH, Erzurum SC. (1998). Characterization of inducible nitric oxide synthase expression in human airway epithelium. Environ Health Perspect 106(Suppl 5):1119–24.
  • Guo M, Sahni SK, Sahni A, Francis CW. (2004). Fibrinogen regulates the expression of inflammatory chemokines through NF-kappaB activation of endothelial cells. Thromb Haemost 92(4):858–66.
  • Guo M, Daines D, Tang J, Shen Q, Perrin RM, Takada Y, Yuan SY, Wu MH. (2009). Fibrinogen-gamma C-terminal fragments induce endothelial barrier dysfunction and microvascular leak via integrin-mediated and RhoA-dependent mechanism. Arterioscler Thromb Vasc Biol 29(3):394–400.
  • Harker LA. (1998). Therapeutic inhibition of platelet function in stroke. Cerebrovasc Dis 5(Suppl 8):8–18.
  • Hattori Y, Kasai K, Gross SS. (2004). NO suppresses while peroxynitrite sustains NF-kappaB: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO. Cardiovasc Res 63:31–40.
  • Idell S. (2003). Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 31(4):S213–20.
  • Ischiropoulos H. (1998). Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 356(1):1–11.
  • Jenkins RG, Su X, Su G, Scotton CJ, Camerer E, Laurent GJ, Davis GE, Chambers RC, Matthay MA, Sheppard D. (2006). Ligation of protease-activated receptor 1 enhances alpha(v) beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 116 (6):1606–14.
  • Jennewein C, Tran N, Paulus P, Ellinghaus P, Eble JA, Zacharowski K. (2011). Novel aspects of fibrin(ogen) fragments during inflammation. Mol Med 17 (5-6):568–73.
  • Jope RS, Zhang L, Song L. (2000). Peroxynitrite modulates the activation of p38 and extracellular regulated kinases in PC12 cells. Arch Biochem Biophys 376 (2):365–70.
  • Kadenbach B. (2003). Intrinsic and extrinsic uncoupling of oxidative phosphorylation. Biochim Biophys Acta 1604 (2):77–94.
  • Kanko M, Ozden M, Maral H, Acil C. (2006). Effect of clopidogrel on nitric oxide levels in an ischemia reperfusion model. J Cardiovasc Pharmacol 48 (1):797–801.
  • Kim SH, Johnson VJ, Sharma RP. (2002). Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression in murine macrophage: differential modulation of NF-κB and p38 MAPK signalling pathways. Nitric Oxide 7 (1):67–74.
  • Kis A, Yellon DM, Baxter GF. (2003). Role of nuclear factor-kappaB activation in acute ischaemia-reperfusion injury in myocardium. Br J Pharmacol 138 (5):894–900.
  • Knepler JL Jr, Taher LN, Gupta MP, Patterson C, Pavalko F, Ober MD, Hart CM. (2001). Peroxynitrite causes endothelial cell monolayer barrier dysfunction. Am J Physiol Cell Physiol 281 (3):C1064–75.
  • Koenen RR, Weber C. (2010). Platelet-derived chemokines in vascular remodeling and atherosclerosis. Semin Thromb Hemost 36 (2):163–9.
  • Konya D, Gercek A, Akakin A, Akakin D, Tural S, Cetinel S, Ozgen S, Pamir MN. (2008). The effects of inflammatory response associated with traumatic spinal cord injury in cutaneous wound healing and on expression of transforming growth factor-beta1 (TGF-β1) and platelet-derived growth factor (PDGF)-A at the wound site in rats. Growth Factors 26 (2):74–9.
  • Krishnadasan B, Naidu BV, Byrne K, Fraga C, Verrier ED, Mulligan MS. (2003). The role of proinflammatory cytokines in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 125 (2):261–72.
  • Krötz F, Sohn HY, Gloe T, Zahler S, Riexinger T, Schiele TM, Becker BF, Theisen K, Klauss V, Pohl U. (2002). NADPH oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 100 (3):917–24.
  • Krötz F, Sohn HY, Pohl U. (2004). Reactive oxygen species: players in the platelet game. Arterioscler Thromb Vasc Biol 24 (11):1988–96.
  • Kuebler WM. (2006). Selectins revisited: the emerging role of platelets in inflammatory lung disease. J Clin Invest 116 (12):3106–8.
  • Kulkarni S, Dopheide SM, Yap CL, Ravanat C, Freund M, Mangin P, Heel KA, Street A, Harper IS, Lanza F, Jackson SP. (2000). A revised model of platelet aggregation. J Clin Invest 105 (6):783–91.
  • Kwon KY, Cho CH, Kang YN, Kim SP, Park KK, Keum DY, Park CK, Jheon SH. (2004). Ultrastructural evaluation of the protective effect of nitroglycerin in preservation-reperfusion injury of rat lungs. Transplant Proc 36 (7):1936–8.
  • Lan Q, Mercurius KO, Davies PF. (1994). Stimulation of transcription factors NF kappa B and AP1 in endothelial cells subjected to shear stress. Biochem Biophys Res Commun 201 (2):950–56.
  • Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. (2003). Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111 (8):1201–9.
  • Leask A. (2010). Potential therapeutic targets for cardiac fibrosis TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 106 (11):1675–80.
  • Lefer AM, Lefer DJ. (1996). The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 32 (4):743–51.
  • Léon C, Hechler B, Vial C, Leray C, Cazenave JP, Gachet C (1997). The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 403 (1):26–30.
  • Li N. (2008). Platelet–lymphocyte cross-talk. J Leukoc Biol 83 (5):1069–78.
  • Li X, Cong H. (2009). Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome. Tex Heart Inst J 36 (2):134–9.
  • Lipinski B. (2001). Pathophysiology of oxidative stress in diabetes mellitus. J Diabetes Complications 15 (4):203–10.
  • Liu X, Miller MJS, Joshi MS, Thomas DD, Lancaster Jr JR. (1998). Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci USA 95 (5):2175–9.
  • Lominadze D, Dean WL, Tyagi SC, Roberts AM. (2010). Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease. Acta Physiologica 198 (1):1–13.
  • López-Neblina F, Páez AJ, Toledo-Pereyra LH. (1995). Modulation of neutrophil infiltration through nitric oxide in the ischemic rat kidney. Transplant Proc 27 (2):1883–5.
  • Loscalzo J. (2001). Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 88 (8):756–62.
  • Loscalzo J. (2003). Oxidant stress: a key determinant of atherothrombosis. Biochem Soc Trans 31 (5):1059–61.
  • Lupidi G, Angeletti M, Eleuteri AM, Tocconi L, Coletta M, Fioretti E. (1999). Peroxynitrite-mediated oxidation of fibrinogen inhibits clot formation. FEBS Lett 462 (3):236–40.
  • MacNee W. (2001). Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 429 (1–3):195–207.
  • Marcus AJ, Broekman MJ, Drosopoulos JHF, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA et al. (1997). The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 99 (6):1351–60.
  • Massberg S, Enders G, Leiderer R, Eisenmenger S, Vestweber D, Krombach F, Messmer K. (1998). Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood 92 (2):507–15.
  • May AE, Kälsch T, Massberg S, Herouy Y, Schmidt R, Gawaz M. (2002). Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 106 (16):2111–17.
  • McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, Jo H, Harrison DG. (2003). Role of xanthine oxidoreductase and NADPH oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 285 (6):H2290–97.
  • Merten M, Pakala R, Thiagarajan P, Benedict CR. (1999). Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 99 (19):2577–82.
  • Miller DL, Roberts AM. (1999). Pulmonary artery occlusion and reperfusion causes microvascular constriction in the rabbit lung. Ann Thorac Surg 67 (2):323–8.
  • Ming XF, Viswambharan H, Barandier C, Ruffieux J, Kaibuchi K, Rusconi S, Yang Z. (2002). Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 22 (24):8467–77.
  • Monaco S, Gioia M, Rodriguez J, Fasciglione GF, Di Pierro D, Lupidi G, Krippahl L, Marini S, Coletta M. (2007). Modulation of the proteolytic activity of matrix metalloproteinase-2 (gelatinase A) on fibrinogen. Biochem J 402 (3):503–13.
  • Monroe, DM, Hoffman M, Roberts HR. (2002). Platelets and thrombin generation. Arteriosclerosis, Thrombosis, and Vascular Biology 22:1381–9.
  • Murphy JT, Duffy SL, Hybki DL, Kamm K. (2001). Thrombin-mediated permeability of human microvascular pulmonary endothelial cells is calcium dependent. J Trauma 50 (2):213–22.
  • Musashi K, Kiryu J, Miyamoto K, Miyahara S, Katsuta H, Tamura H, Hirose F, Yoshimura N. (2005). Thrombin inhibitor reduces leukocyte–endothelial cell interactions and vascular leakage after scatter laser photocoagulation. Invest Ophthalmol Vis Sci 46 (7):2561–6.
  • Naidu BV, Krishnadasan B, Farivar AS, Woolley SM, Thomas R, Van Rooijen N, Verrier ED, Mulligan MS. (2003). Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 126 (1):200–7.
  • Nowak P, Wachowicz B. (2002). Peroxynitrite-mediated modification of fibrinogen affects platelet aggregation and adhesion. Platelets 13 (5–6):293–9.
  • Nowak P, Zbikowska HM, Ponczek M, Kolodziejczyk J, Wachowicz B. (2007). Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: functional consequences. Thromb Res 121 (2):163–74.
  • Ohmori H, Dhar DK, Nakashima Y, Hashimoto M, Masumura S, Nagasue N. (1998). Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver Transplantation 66(5):579–85.
  • Ovechkin AV, Lominadze D, Sedoris KC, Gozal E, Robinson TW, Roberts AM. (2005). Inhibition of inducible nitric oxide synthase attenuates platelet adhesion in subpleural arterioles caused by lung ischemia-reperfusion in rabbits. J Appl Physiol 99(6):2423–32.
  • Ovechkin AV, Lominadze D, Sedoris KC, Robinson TW, Tyagi SC, Roberts AM. (2007). Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions. Arch Physiol Biochem 113(1):1–12.
  • Parastatidis I, Thomson L, Burke A, Chernysh I, Nagaswami C, Visser J, Stamer S, Liebler DC, Koliakos G, Heijnen HF et al. (2008). Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor. J Biol Chem 283(49):33846–53.
  • Parviz M, Bousamra M 2nd, Chammas JH, Birks EK, Presberg KW, Jacobs ER, Nelin LD. (1999). Effects of chronic pulmonary overcirculation on pulmonary vasomotor tone. Ann Thorac Surg 67(2):522–7.
  • Pfeilschifter J, Eberhardt W, Huwiler A. (2001). Nitric oxide and mechanisms of redox signalling: matrix and matrix-metabolizing enzymes as prime nitric oxide targets. Eur J Pharmacol 429(1–3):279–86.
  • Phelps DT, Ferro TJ, Higgins PJ, Shankar R, Parker DM, Johnson A. (1995). TNF-alpha induces peroxynitrite–mediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol 269(4 pt 1):L551–9.
  • Phillips L, Toledo AH, Lopez-Neblina F, Anaya-Prado R, Toledo-Pereyra LH. (2009). Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg 22(1):46–55.
  • Pluskota E, D’Souza SE. (2000). Fibrinogen interactions with ICAM-1 (CD54) regulates endothelial cell survival. Eur J Biochem 267(15):4693–704.
  • Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE, Sessa WC. (2001). Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 276(21):17621–4.
  • Radomski MW, Palmer RM, Moncada S. (1987). Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2(8567):1057–58.
  • Rauch BH, Müschenborn B, Braun M, Weber AA, Schrör K. (2007). ICAM-1 and p38 MAPK mediate fibrinogen-induced migration of human vascular smooth muscle cells. Eur J Pharmacol 577(1–3):54–7.
  • Reneman RS, Arts T, Hoeks AP. (2006). Wall shear stress – an important determinant of endothelial cell function and structure – in the arterial system in vivo. Discrepancies with theory. J Vasc Res 43(3):251–69.
  • Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. (2005). Incidence and outcomes of acute lung injury. N Engl J Med 353:1685–93.
  • Rudkowski JC, Barreiro E, Harfouche R, Goldberg P, Kishta O, D’Orleans-Juste P, Labonte J, Lesur V, Hussain SN. (2004). Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. Am J Physiol Lung Cell Mol Physiol 286(4):L793–800.
  • Ruggeri ZM. (2002). Platelets in atherothrombosis. Nat Med 8(11):1227–34.
  • Sase K, Michel T. (1995). Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci 57(22):2049–55.
  • Scandura JM, Walsh PN. (1996). Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa. Biochemistry 35(27):8903–13.
  • Sedoris KC, Ovechkin AV, Gozal E, Roberts AM. (2009). Differential effects of nitric oxide synthesis on pulmonary vascular function during lung ischemia-reperfusion injury. Arch Physiol Biochem 115(1):34–46.
  • Sedoris KC, Gozal E, Ovechkin AV, Theile AR, Roberts AM. (2011). Interplay of endothelial and inducible nitric oxide synthases modulates the vascular response to ischaemia-reperfusion in the rabbit lung. Acta Physiol (Oxf). (E-pub ahead of print)
  • Shacka JJ, Sahawneh MA, Gonzalez JD, Ye YZ, D’Alessandro TL, Estévez AG. (2006). Two distinct signalling pathways regulate peroxynitrite-induced apoptosis in PC12 cells. Cell Death Differ 13(9):1506–14.
  • Singbartl K, Forlow SB, Ley K. (2001). Platelet, but not endothelial, P-selectin is critical for neutrophil- mediated acute postischemic renal failure. FASEB J C5(13):2337–44.
  • Soccal PM, Gasche Y, Pache JC, Schneuwly O, Slosman DO, Morel DR, Spiliopoulos A, Suter PM, Nicod LP. (2000). Matrix metalloproteinases correlate with alveolar-capillary permeability alteration in lung ischemia-reperfusion injury. Transplantation 70(7):998–1005.
  • Spear N, Estevéz AG, Barbeito L, Beckman JS, Johnson GV. (1997). Nerve growth factor protects PC12 cells against peroxynitrite-induced apoptosis via a mechanism dependent on phosphatidylinositol 3-kinase. J Neurochem 69(1):53–9.
  • Spiecker M, Darius H, Kaboth K, Hübner F, Liao JK. (1998). Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukocyte Biol 63(6):732–9.
  • Sud N, Sharma S, Wiseman DA, Harmon C, Kumar S, Venema RC, Fineman JR, Black SM. (2007). Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90. Am J Physiol Lung Cell Mol Physiol 293(6):L1444–53.
  • Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. (2003). New markers of inflammation and endothelial cell activation: Part I. Circulation 108(16):1917–23.
  • Turko IV, Murad F. (2002). Protein nitration in cardiovascular diseases. Pharmacol Rev 54(4):619–34.
  • van der Heijdan M, Versteilen AM, Sipkema P, van Nieuw Amerongen GP, Musters RJ, Growneveld AB. (2008). Rho-kinase-dependent F-actin rearrangement is involved in the inhibition of PI3-kinase/Akt during ischemia–reperfusion-induced endothelial cell apoptosis. Apoptosis 13(3):404–12.
  • van Gils JM, Zwaginga JJ, Hordijk PL. (2009). Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 85(2):195–204.
  • Vadseth C, Souza JM, Thomson L, Seagraves A, Nagaswami C, Scheiner T, Torbet J, Vilaire G, Bennett JS, Murciano JC et al. (2004). Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J Biol Chem 279(10):8820–26.
  • Viñas JL, Hotter G, Pi F, Palacios L, Sola A. (2007). Role of peroxynitrite on cytoskeleton alterations and apoptosis in renal ischemia-reperfusion. Am J Physiol Renal Physiol 292(6):F1673–80.
  • Vink H, Constantinescu AA, Spaan JA. (2000). Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 101:1500–2.
  • Wagner DD, Burger PC. (2003). Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 23(12):2131–7.
  • Wallentin L. (2009). P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. Eur Heart J 30(16):1964–77.
  • Ware LB, Matthay MA. (2000). The acute respiratory distress syndrome. N Engl J Med 342:1334–49.
  • Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P, Liao JK. (2004). Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 24(10):1842–7.
  • Wu B, Liu G, Yube K, Ueno M, Tanaka S, Onodera M, Jin Z, Sakamoto H. (2009). Effects of platelet release products on neutrophilic activity in human whole blood. Inflamm Res 58(6):321–8.
  • Xu Y, Huo Y, Toufektsian MC, Ramos SI, Ma Y, Tejani AD, French BA, Yang Z. (2006). Activated platelets contribute importantly to myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 290(2):H692–9.
  • Zarbock A, Ley K. (2006). The role of platelets in acute lung injury. Front Biosci 14:150–58.
  • Zarbock A, Singbartl K, Ley K. (2006). Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 116(12):3211–9.
  • Zarbock A, Polanowska-Grabowska RK, Ley K. (2007). Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev 21(2):99–111.
  • Zarbock A, Ley K. (2008). Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol 172(1):1–7.
  • Zhao YY, Malik AB. (2009). A novel insight into the mechanism of pulmonary hypertension involving caveolin-1 deficiency and eNOS activation. Trends Cardiovasc Med 19(7):238–42.
  • Zhou JL, Jin GH, Yi YL, Zhang JL, Huang XL. (2003). Role of nitric oxide and peroxynitrite anion in lung injury induced by intestinal ischemia-reperfusion in rats. World J Gastroenterol 9(6):1318–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.